INS and hyperlipidemia: However, in spite of the extensive access of insulin and other medications in Iran for patients with diabetes, the estimated national control of hyperglycemia, hyperlipidemia and hypertension exclusively for old women and young men remains insufficient and the prevalence of chronic cardiovascular disease among these patients are relatively high in Iran [30].